SCHEMBL1432166

SCHEMBL1432166

CC(=O)C(Cl)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 2/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ AKR1C2 P52895 2/20 0.42
▸ AKR1C3 P42330 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ TSHR P16473 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TYR P14679 1/20 0.41
▸ SRD5A2 P31213 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ FFAR1 O14842 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ AKR1C1 Q04828 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9276609 0.78 TSHR (0.54) NR1H4HDAC1AKR1C2AKR1C3POLB
SCHEMBL12267916 0.78 NR1H4 (0.57) NR1H4HDAC1AKR1C2AKR1C3TSHR
SCHEMBL3993198 0.77 SMN1; SMN2 (0.42) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL2551253 0.77 ESR1 (0.50) NR1H4TSHRALDH1A1LMNACYP1A2
SCHEMBL3993817 0.77 BRD4 (0.61) TSHRLMNACYP1A2MEN1KMT2A
SCHEMBL6258304 0.76 FFAR1 (0.43) NR1H4HDAC1POLBTSHRALDH1A1
SCHEMBL4052998 0.75 ACACB (0.40) ALDH1A1LMNAMAPT
SCHEMBL3993015 0.75 CYP1A2 (0.53) POLBCYP1A2SMN1; SMN2
SCHEMBL1511329 0.75 HDAC3 (0.44) HDAC1POLBALDH1A1LMNASMN1; SMN2
SCHEMBL356020 0.74 LMNA (0.47) TSHRALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403846-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE F. Hoffmann-La Roche AG (CH) 2012-01-11 — — EP disclosed
EP-2300459-A1 NOVEL PHENYLPYRAZINONES AS KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2011-03-30 — — EP disclosed
EP-2242749-A1 NOVEL PYRIDINONES AND PYRIDAZINONES F. Hoffmann-La Roche AG (CH) 2010-10-27 — — EP disclosed
WO-2010100070-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE F. HOFFMANN-LA ROCHE AG (CH) 2010-09-10 — — WO disclosed
WO-2010000633-A1 NOVEL PHENYLPYRAZINONES AS KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-01-07 — — WO disclosed
WO-2009098144-A1 NOVEL PYRIDINONES AND PYRIDAZINONES F. HOFFMANN-LA ROCHE AG (CH) 2009-08-13 — — WO disclosed
EP-1658269-A1 FUSED COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR Abbott Laboratories (US) 2006-05-24 — — EP disclosed
WO-2004111009-A1 FUSED COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR ABBOTT LABORATORIES (US) 2004-12-23 — — WO disclosed
Send feedback